{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:56:39Z","timestamp":1767963399799,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis Supplements"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.atherosclerosissup.2012.10.024","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T17:33:35Z","timestamp":1359221615000},"page":"161-165","source":"Crossref","is-referenced-by-count":23,"title":["Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies \u2013 Perspectives for immunoadsorption"],"prefix":"10.1016","volume":"14","author":[{"given":"Reinhard","family":"Klingel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Heibges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cordula","family":"Fassbender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jca.20317","article-title":"A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis","volume":"26","author":"Koehler","year":"2011","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12028-009-9252-6","article-title":"Selective immune adsorption treatment of severe Guillain\u2013Barr\u00e9-syndrome in the intensive care unit","volume":"11","author":"Galldiks","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clineuro.2004.12.019","article-title":"Factors influencing outcome in Guillain\u2013Barr\u00e9 syndrome: comparison of plasma adsorption against other treatments","volume":"107","author":"Seta","year":"2005","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood-2002-01-0128","article-title":"Influence of plasma immunoglobulin level on antibody synthesis","volume":"100","author":"Goldammer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbadis.2010.06.009","article-title":"The role of antibodies in multiple sclerosis","volume":"1812","author":"Weber","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl. 3","key":"10.1016\/j.atherosclerosissup.2012.10.024_bib7","doi-asserted-by":"crossref","first-page":"III10","DOI":"10.1007\/s00415-005-2011-5","article-title":"Clinical implications of neuropathological findings in multiple sclerosis","volume":"252","author":"Brueck","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib9","series-title":"Guidelines for diagnosis and therapy in neurology","year":"2008"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib10","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00415-008-0061-1","article-title":"Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations","volume":"255","author":"Multiple Sclerosis Therapy Consensus Group (MSTCG)","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0140-6736(91)93389-Q","article-title":"The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis","volume":"337","author":"Canadian Cooperative Multiple Sclerosis Study Group","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.39.9.1143","article-title":"Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis","volume":"39","author":"Weiner","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archneurol.2011.34","article-title":"Beneficial plasma exchange response in central nervous system inflammatory demyelination","volume":"68","author":"Magana","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib15","first-page":"105","article-title":"Therapeutic plasma exchange for steroid unresponsive multiple sclerosis relapses \u2013 a long-term follow-up observation including 35 patients","volume":"36","author":"Schroeder","year":"2009","journal-title":"Akt Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000224630","article-title":"Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis","volume":"28","author":"Trebst","year":"2009","journal-title":"Blood Purif"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib17","first-page":"601","article-title":"Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses","volume":"30","author":"deAndres","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib18","first-page":"173","article-title":"Immunoadsorption and plasma exchange in 10 pediatric patients with acute corticosteroid refractory relapse of demyelinating diseases of the central nervous system","volume":"3","author":"Koziolek","year":"2011","journal-title":"Mitteil DGfN"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-9-80","article-title":"Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis","volume":"9","author":"Koziolek","year":"2012","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib20","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00115-011-3324-5","article-title":"Immunoadsorption for steroid-unresponsive multiple sclerosis-relapses. Clinical data of 14 patients","volume":"82","author":"Mauch","year":"2011","journal-title":"Nervenarzt"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib21","first-page":"174","article-title":"Immunoadsorption as relapse escalation therapy in multiple sclerosis","volume":"39","author":"Schimrigk","year":"2012","journal-title":"Akt Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000332397","article-title":"Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis","volume":"33","author":"Trebst","year":"2012","journal-title":"Blood Purif"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib23","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","article-title":"Treatment of progressive multifocal leukoencephalopathy associated with natalizumab","volume":"361","author":"Wenning","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicenter study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib26","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00115-010-3192-4","article-title":"Diagnosis and therapy of neuromyelitis optica","volume":"82","author":"Trebst","year":"2011","journal-title":"Nervenarzt"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jocn.2010.05.030","article-title":"The rescue effect of plasma exchange for neuromyelitis optica","volume":"18","author":"Wang","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1744-9987.2009.00780.x","article-title":"Intermittent plasmapheresis prevents recurrence in neuromyelitis optica","volume":"13","author":"Miyamoto","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/01.wnl.0000325917.48466.55","article-title":"Neuronal surface antigen antibodies in limbic encephalitis","volume":"71","author":"Graus","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jocn.2007.12.003","article-title":"Limbic encephalitis \u2013 a review","volume":"15","author":"Anderson","year":"2008","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00115-011-3257-z","article-title":"Antibody-associated diseases of the gray matter of the CNS: diagnosis and treatment","volume":"82","author":"Bien","year":"2011","journal-title":"Nervenarzt"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0031-1277985","article-title":"Autoimmune encephalopathy","volume":"31","author":"Flanagan","year":"2011","journal-title":"Semin Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0404.2011.01549.x","article-title":"Onconeural antibodies in patients with neurological symptoms: detection and clinical significance","volume":"191","author":"Raspotnig","year":"2011","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib38","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00115-010-3219-x","article-title":"Autoimmune synaptic encephalopathies","volume":"82","author":"Friese","year":"2011","journal-title":"Nervenarzt"},{"key":"10.1016\/j.atherosclerosissup.2012.10.024_bib39","unstructured":"Ehrlich S, Fassbender C, Blaes F, et\u00a0al. Therapeutic apheresis for patients with autoimmune encephalitis, in press."}],"container-title":["Atherosclerosis Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568812000359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568812000359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T23:00:31Z","timestamp":1562626831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567568812000359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1567568812000359"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2012.10.024","relation":{},"ISSN":["1567-5688"],"issn-type":[{"value":"1567-5688","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}